Fitness costs of resistance to antimalarial drugs

Trends in Parasitology

Volumn 24, Issue 8, 2008, Pages 331-333

  Felger, Ingrid ^a   Beck, Hans Peter ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

GENE MUTATION; HAPLOTYPE; HUMAN; MALARIA; NONHUMAN; PARASITE SURVIVAL; PARASITE TRANSMISSION; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; SEASONAL VARIATION; SHORT SURVEY;

ANIMALS; ANTIMALARIALS; CHILD; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MALARIA; PLASMODIUM; SEASONS;

EID: 47649091364     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2008.05.004     Document Type: Short Survey

References (14)

1. Hastings I.M., and Donnelly M.J. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist. Updat. 8 (2005) 43-50
2. Walliker D., et al. Fitness of drug-resistant malaria parasites. Acta Trop. 94 (2005) 251-259
3. Koella J.C., and Antia R. Epidemiological models for the spread of anti-malarial resistance. Malar. J. 2 (2003) 3
4. Kublin J.G., et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003) 1870-1875
5. Holmgren G., et al. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect. Genet. Evol. 7 (2007) 562-569
6. Sisowath C., et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191 (2005) 1014-1017
7. Hayward R., et al. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 55 (2005) 1285-1295
8. de Roode J.C., et al. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar. J. 3 (2004) 33
9. Babiker H.A., et al. Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 94 (2005) 260-268
10. Ord R., et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 196 (2007) 1613-1619
11. Osman M.E., et al. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum. Infect. Genet. Evol. 7 (2007) 52-59
12. Schoepflin S., et al. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population. Malar. J. 7 (2008) 78
13. Kun J.F., et al. New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. Am. J. Trop. Med. Hyg. 66 (2002) 653-658
14. Crameri A., et al. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. J. Clin. Microbiol. 45 (2007) 3685-3691